PALI 9 (Invega 9 mg)
Generic Name: paliperidone
Pill imprint PALI 9 has been identified as Invega 9 mg.
Invega is used in the treatment of schizoaffective disorder; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Invega 9 mg is not a controlled substance under the Controlled Substance Act (CSA).
Invega
- Generic Name:
- paliperidone
- Imprint:
- PALI 9
- Strength:
- 9 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Janssen Pharmaceuticals
- National Drug Code (NDC):
- 50458-0552
- Inactive Ingredients:
- carnauba wax
cellulose acetate
polyethylene glycol
propylene glycol
povidone
sodium chloride
stearic acid
butylated hydroxytoluene
hypromelloses
titanium dioxide
ferrosoferric oxide
More about Invega (paliperidone)
Consumer resources
- Other brands: Invega Trinza
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
